New Ways to Attack Atopic Dermatitis: Realm Expects POC Next Quarter

 
• By John Davis

Realm Therapeutics is evaluating a substance derived from insights into innate immunity that has potential as an immunomodulator in various dermatological disorders, including atopic dermatitis and acne, with proof-of-concept (POC) expected in the third quarter.

Prof of Concept
• Source: Shutterstock

More from Clinical Trials

More from R&D